Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4503)
All Articles published online
|
Publishing Process of This Article
|
Sep 26, 2022 (publication date) through Apr 30, 2025
Times Cited of This Article
- Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu SG, Li HB, Dai TX, Li H, Wang GY. Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report. World J Clin Cases 2022; 10(27): 9743-9749 [PMID: 36186195 DOI: 10.12998/wjcc.v10.i27.9743] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i27/9743.htm |
| Number | Citing Articles |
| 1 |
Qian Xu, Jiahui Chu, Qinqin Hu, Yanheng Sun, Fan Jiang, Song Li, Lian Liu. The role and clinical significance of tumor-draining lymph nodes in tumor progression and immunotherapy. Critical Reviews in Oncology/Hematology 2025; : 104745 doi: 10.1016/j.critrevonc.2025.104745
|
| 2 |
Fei Chen, Jian Sheng, Xiaoping Li, Zhaofeng Gao, Siqi Zhao, Lingyu Hu, Minjie Chen, Jianguo Fei, Zhengwei Song. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma. Biomedicine & Pharmacotherapy 2024; 175: 116659 doi: 10.1016/j.biopha.2024.116659
|
| 3 |
Feng Xian, Dacheng Ren, Jun Bie, Guohui Xu. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1119168
|
| 4 |
Ruyu Han, Peipei Song, Wei Tang, Tianqiang Song, Lu Chen. Advances in neoadjuvant therapy for resectable intrahepatic cholangiocarcinoma: An invited commentary. Oncology and Translational Medicine 2025; 11(1): 1 doi: 10.1097/ot9.0000000000000068
|